Key result
Reimbursement for cardiac CTA and new procedures often outpaces evidence of clinical benefit, driving costs.
Answers are grounded in this paper and cite their sources.
The average American might assume that new medical procedures are proved beneficial before insurers pay for them. In reality, many new procedures are paid for even with no persuasive evidence of benefit. One consequence is health care expenditures that are growing substantially faster than the economy and a Medicare program projected to become insolvent in the next decade. Increased use of technology is the largest driver of this growth; its effect dwarfs that of the aging of our population. We should be able to curb these costs and increase value in health care by taking an evidence-based approach to insurance . . .
No takes yet. Share an insight, caveat, or question.
Redberg et al. (2008) reported an editorial. Cardiac computed tomographic angiography was evaluated. Cardiac computed tomographic angiography and other new medical procedures are often reimbursed without persuasive evidence of clinical benefit, driving rapid health care expenditure growth.
Synapse has enriched 10 related papers. Consider them for comparative context: